Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction

International Journal of Molecular Medicine

Volumn 35, Issue 1, 2015, Pages 92-102

  Wang, Bo ^a   Xu, Wenming ^a   Tan, Miaolian ^a   Xiao, Yan ^a   Yang, Haiwei ^b   Xia, Tian Song ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Comparative genomics; Interleukin 34; Meta analysis; Prognosis

Indexed keywords

CYTOKINE; FORKHEAD L1 TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 34; POU DOMAIN CLASS 3 TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BRAIN CANCER; BREAST CANCER; CANCER PROGNOSIS; COLORECTAL CANCER; EXON; EYE CANCER; GENE EXPRESSION; GENE IDENTIFICATION; GENOMICS; HEAD AND NECK CANCER; HUMAN; INTRON; LUNG CANCER; MAMMAL; MISSENSE MUTATION; NEOPLASM; NON SMALL CELL LUNG CANCER; NONHUMAN; NONSENSE MUTATION; OVARY CANCER; PHYLOGENETIC TREE; PRIMATE; PROMOTER REGION; RODENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SOMATIC MUTATION; TELEOST; VERTEBRATE; ALTERNATIVE RNA SPLICING; ANIMAL; CHEMISTRY; GENE EXPRESSION PROFILING; GENE ORDER; GENETIC DATABASE; GENETICS; META ANALYSIS (TOPIC); METABOLISM; MOLECULAR GENETICS; MUTATION; NEOPLASMS; PHYLOGENY; PROCEDURES; PROGNOSIS; PROTEOMICS; SEQUENCE ALIGNMENT;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CYTOKINES; DATABASES, GENETIC; EXONS; GENE EXPRESSION PROFILING; GENE ORDER; GENOMICS; HUMANS; INTERLEUKINS; INTRONS; META-ANALYSIS AS TOPIC; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEOMICS; SEQUENCE ALIGNMENT; VERTEBRATES;

EID: 84917737817     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.2001     Document Type: Article

References (49)

1. Wakabayashi S, Yamaguchi K, Kumakura S, et al: Effects of anesthesia with sevoflurane and propofol on the cytokine/chemokine production at the airway epithelium during esophagectomy. Int J Mol Med 34: 137-144, 2014.
2. Signorelli SS, Fiore V and Malaponte G: Inflammation and peripheral arterial disease: the value of circulating biomarkers (Review). Int J Mol Med 33: 777-783, 2014.
3. Clavel G, Thiolat A and Boissier MC: Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine 80: 449-453, 2013.
4. Lin H, Lee E, Hestir K, Leo C, et al: Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320: 807-811, 2008.
5. Boström EA and Lundberg P: The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PLoS One 8: e81665, 2013.
6. Moon SJ, Hong YS, Ju JH, Kwok SK, Park SH and Min JK: Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol 40: 1842-1849, 2013.
7. Hwang SJ, Choi B, Kang SS, et al: Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res Ther 14: R14, 2012.
8. Chen Z, Buki K, Vääräniemi J, Gu G and Väänänen HK: The critical role of IL-34 in osteoclastogenesis. PLoS One 6: e18689, 2011.
9. El-Gamal MI, Anbar HS, Yoo KH and Oh CH: FMS kinase inhibitors: Current status and future prospects. Med Res Rev 33: 599-636, 2013.
10. Burns CJ and Wilks AF: c-FMS inhibitors: a patent review. Expert Opin Ther Pat 21: 147-165, 2011.
11. Baud'huin M, Renault R, Charrier C, et al: Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol 221: 77-86, 2010.
12. Petráčková M, Staněk L, Mandys V, Dundr P and Vonka V: Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF. Int J Oncol 40: 1915-1922, 2012.
13. Fournier P, Aigner M and Schirrmacher V: Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity. Int J Oncol 38: 1719-1729, 2011.
14. Kitoh Y, Saio M, Gotoh N, et al: Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro. Int J Oncol 38: 1409-1419, 2011.
15. Tada F, Abe M, Hirooka M, et al: Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Int J Oncol 41: 1601-1609, 2012.
16. Yang L, Luo Y and Wei J: Integrative genomic analyses on Ikaros and its expression related to solid cancer prognosis. Oncol Rep 24: 571-577, 2010.
17. Yang L, Luo Y, Wei J and He S: Integrative genomic analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and -λ3. Int J Mol Med 25: 807-812, 2010.
18. Yang L, Wei J and He S: Integrative genomic analyses on interferon-λs and their roles in cancer prediction. Int J Mol Med 25: 299-304, 2010.
19. Yu H, Yuan J, Xiao C and Qin Y: Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer. Int J Mol Med 31: 1248-1254, 2013.
20. Wang M, Wei X, Shi L, Chen B, Zhao G and Yang H: Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction. Int J Mol Med 33: 1019-1026, 2014.
21. Wang B, Chen K, Xu W, Chen D, Tang W and Xia TS: Integrative genomic analyses of secreted protein acidic and rich in cysteine and its role in cancer prediction. Mol Med Rep 10: 1461-1468, 2014.
22. Kumar S, Nei M, Dudley J and Tamura K: MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9: 299-306, 2008.
23. Yang Z: PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555-556, 1997.
24. Yang Z, Nielsen R, Goldman N and Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431-449, 2000.
25. Forbes SA, Bindal N, Bamford S, et al: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945-D950, 2011.
26. Katoh Y and Katoh M: Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFβ-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int J Oncol 35: 187-192, 2009.
27. Katoh M and Katoh M: Integrative genomic analyses of WNT11: transcriptional mechanisms based on canonical WNT signals and GATA transcription factors signaling. Int J Mol Med 24: 247-251, 2009.
28. Katoh M and Katoh M: Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades. Int J Mol Med 23: 763-769, 2009.
29. Katoh M and Katoh M: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1α, POU/OCT, and NF-κB. Int J Oncol 34: 1737-1742, 2009.
30. Chalifa-Caspi V, Yanai I, Ophir R, et al: GeneAnnot: comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. Bioinformatics 20: 1457-1458, 2004.
31. Parkinson H, Sarkans U, Shojatalab M, et al: ArrayExpress - a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 33: D553-D555, 2005.
32. Mizuno H, Kitada K, Nakai K and Sarai A: PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2: 18, 2009.
33. Wang T, Kono T, Monte MM, et al: Identification of IL-34 in teleost fish: differential expression of rainbow trout IL-34, MCSF1 and MCSF2, ligands of the MCSF receptor. Mol Immunol 53: 398-409, 2013.
34. Bouafia A, Corre S, Gilot D, Mouchet N, Prince S and Galibert MD: p53 requires the stress sensor USF1 to direct appropriate cell fate decision. PLoS Genet 10: e1004309, 2014.
35. Ikeda R, Nishizawa Y, Tajitsu Y, et al: Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells. Oncol Rep 31: 197-201, 2014.
36. Katoh Y and Katoh M: Comparative genomics on Vangl1 and Vangl2 genes. Int J Oncol 26: 1435-1440, 2005.
37. Feng C, Zhang Y, Yin J, Li J, Abounader R and Zuo Z: Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol 16: 1078-1085, 2014.
38. Xu F, Zhu X, Han T, et al: The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1. Int J Oncol 45: 255-263, 2014.
39. Liang X, Li ZL, Jiang LL, Guo QQ, Liu MJ and Nan KJ: Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1. Int J Oncol 44: 1989-1997, 2014.
40. Chae JI, Cho JH, Lee KA, et al: Role of transcription factor Sp1 in the quercetin-mediated inhibitory effect on human malignant pleural mesothelioma. Int J Mol Med 30: 835-841, 2012.
41. Lee KA, Lee YJ, Ban JO, et al: The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1. Int J Mol Med 30: 21-27, 2012.
42. Moritsugu R, Tamai K, Nakano H, et al: Functional analysis of the nuclear localization signal of the POU transcription factor Skn-1a in epidermal keratinocytes. Int J Mol Med 34: 539-544, 2014.
43. Katoh M and Katoh M: Human FOX gene family (Review). Int J Oncol 25: 1495-1500, 2004.
44. Katoh M and Katoh M: Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals. Int J Oncol 34: 1411-1415, 2009.
45. Metzeler KH, Hummel M, Bloomfield CD, et al: An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112: 4193-4201, 2008.
46. Freije WA, Castro-Vargas FE, Fang Z, et al: Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64: 6503-6510, 2004.
47. Smith JJ, Deane NG, Wu F, et al: Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968, 2010.
48. Okayama H, Kohno T, Ishii Y, et al: Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 72: 100-111, 2012.
49. Lee ES, Son DS, Kim SH, et al: Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 14: 7397-7404, 2008.